Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02500407 |
|---|---|
| Brief Title: | A Safety, Efficacy and Pharmacokinetic Study of BTCT4465A (Mosunetuzumab) as a Single Agent and Combined With Atezolizumab in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL) |
| First Submitted : | July 14, 2015 |
| First Submitted that Met QC Criteria : | July 14, 2015 |
| First Posted : | July 16, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | May 2, 2024 |
| Last Update Posted : | May 3, 2024 |